Demonstrates that proteolysis of myofibrils in the presence of EDTA yields a single enzymatically active myosin subfragment similar to heavy-meromyosin subfragment 1.
Answers are grounded in this paper and cite their sources.
Animal proteolysis data warrant no clinical change; leaves open whether EDTA yields superior human cardiac myosin subfragments.
Myofibrils, when submitted to proteolysis, yield several fragments, some of which remain bound to actin. There are separated by pyrophosphate treatment and isolated by preparative centrifugation. When trypsin treatment is performed in the presence of 1 mM CaCl 2 , two types of products are obtained, which can be separated by chromatography on DEAE‐cellulose. However, when proteolysis is performed with 10 mM EDTA in the medium, only one enzymatically active fragment is isolated. It is characterized by its sedimentation coefficient, α‐helix content, amino‐acid composition, actin‐binding properties in the absence of ATP and actin‐activation of its enzymatic activity. It is thus shown that the EDTA type fragment is similar to heavy‐mero‐myosin subfragment 1 obtained by direct treatment of myosin or heavy meromyosin with papain or trypsin.
No takes yet. Share an insight, caveat, or question.
Biró et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: